International Stem Cell CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OQB
International Stem Cell Corp's Director Don Wright was granted 562,786 stock options with an exercise price of $0.13, vesting through June 2026 and expiring in June 2035.
OQB
Paul V. Maier, a Director at International Stem Cell Corp., was granted stock options for a total of 562,786 shares of common stock with an exercise price of $0.13 per share.
OQB
Director Don Wright acquired stock options in International Stem Cell CORP on June 11, 2024.
OQB
Paul V. Maier, a director at International Stem Cell CORP, reports the acquisition of stock options.